Medtronic diabetes unit MiniMed seeks up to 784 million dollars in US stock market debut
Medtronic's diabetes unit MiniMed Group announced today its plans to raise up to 784 million dollars. The firm is seeking an initial public offering in the US.
Insights:
MiniMed Group, the diabetes business of Medtronic plc , announced plans on February 24, 2026, to raise up to $784 million through an initial public offering in the United States 
US. The announcement represents a significant corporate portfolio action by the major medical-device company, carrying direct implications for the corporate structure and valuation of Medtronic.
US. The announcement represents a significant corporate portfolio action by the major medical-device company, carrying direct implications for the corporate structure and valuation of Medtronic.
